ViiV and Chelsea & Westminster Hospital launch digital service for HIV patients

pharmafile | January 18, 2021 | News story | Sales and Marketing HIV, ViiV Healthcare 

Global specialist HIV company ViiV Healthcare and Chelsea and Westminster Hospital NHS Foundation Trust have launched a new service, Klick, which leverages digital technology to provide HIV patients with improved access to the most appropriate care.

Created under a Joint Working Agreement, Klick uses digital clinic tools to triage patients according to clinical need, and is supported by a mobile app that allows patients to manage appointments, complete health assessments, review results and communicate with their healthcare team.

The new service is being gradually launched to patients at Chelsea and Westminster Hospital’s Kobler Outpatient Clinic, one of the largest centres of HIV care in Europe, with plans to expand to larger patient populations across multiple sites at the Trust in the coming months. The launch follows positive results generated through a pilot, also in the form of a Joint Working Agreement, which were presented at last year’s British HIV Association (BHIVA) Annual Congress and demonstrated exceptionally high levels of patient satisfaction and quality of care.

Klick has also been designed to respond to the current demands on HIV healthcare services brought by the COVID-19 pandemic, allowing outpatient clinics to rapidly evaluate clinical needs, provide access to care remotely and communicate effectively with patients. The design and implementation of the service has been led by a project team comprising individuals from ViiV Healthcare’s innovation team, along with clinical and non-clinical staff from the Kobler Clinic. The service has been designed with a focus on ensuring digital solutions can integrate with and enhance the service model, whilst delivering a positive experience for patients.

Dr Thomas Van Every, Global Medical Affairs Director at ViiV Healthcare, said: “All too often, innovations in healthcare fail when placed into the complex environment of a health system. ViiV Healthcare’s innovation specialists design solutions which leverage technology but are also rooted in the science of implementation. This demonstrates our commitment to understanding the drivers and barriers to implementing innovations in real-world settings.

“Our partnership with Chelsea and Westminster Hospital NHS Foundation Trust has combined experience in innovation with delivering quality care to patients within the NHS. The output is a robustly tested service for HIV patients, designed to be fit for the future of HIV care.”

Darcy Jimenez

Related Content

FDA relaxes blood donation regulations for MSM

The US Food and Drug Administration (FDA) has released updated guidance for blood donation which …

GSK’s ViiV and Halozyme to collaborate on ‘ultra-long acting’ HIV drugs

ViiV Healthcare, the specialist HIV company majority owned by GlaxoSmithKline (GSK), is to collaborate with …

New HIV prevention drug application submitted to FDA

ViiV Healthcare have initiated a rolling submission of a new drug application (NDA) with the …

Latest content